Detalhe da pesquisa
1.
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview.
Lancet Oncol
; 23(9): e406-e415, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055309
2.
Relatively mild symptoms after chronic overdose with a double-dose encorafenib: a case report.
Anticancer Drugs
; 32(5): 589-591, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587356
3.
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Lancet Oncol
; 20(4): e200-e207, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30942181
4.
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib.
Br J Clin Pharmacol
; 83(10): 2195-2204, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28500677
5.
Use of the Child-Pugh score in anticancer drug dosing decision making: proceed with caution - Authors' reply.
Lancet Oncol
; 20(6): e290, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162097
6.
Plasma concentrations of tyrosine kinase inhibitors imatinib, erlotinib, and sunitinib in routine clinical outpatient cancer care.
Ther Drug Monit
; 36(3): 326-34, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24305627
7.
Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring.
Ther Drug Monit
; 35(2): 168-76, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23503442
8.
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome.
Eur J Clin Pharmacol
; 69(12): 2065-72, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23995862
9.
Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.
Int J Cancer
; 130(1): 223-33, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21351087
10.
P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinib.
J Pharmacol Exp Ther
; 341(1): 164-73, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22238213
11.
Erlotinib and pantoprazole: a relevant interaction or not?
Br J Clin Pharmacol
; 70(6): 908-11, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21175447
12.
Concentrations of Erlotinib in Tumor Tissue and Plasma in Non-Small-Cell Lung Cancer Patients After Neoadjuvant Therapy.
Clin Lung Cancer
; 16(4): 320-4, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682545
13.
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study.
Leuk Res
; 38(1): 34-41, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24238639
14.
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
J Anal Toxicol
; 35(8): 558-65, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22004675
15.
Phase 1 study of combination treatment with PTK 787/ZK 222584 and cetuximab for patients with advanced solid tumors: safety, pharmacokinetics, pharmacodynamics analysis.
Neoplasia
; 12(2): 206-13, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20126478
16.
Relatively mild symptoms after an olanzapine intoxication in a 2-year-old girl with excessively high serum levels.
J Child Adolesc Psychopharmacol
; 21(1): 93-5, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21288123